Xu Li
- Topics
- Atrial Fibrillation Management and Outcomes (5 papers)Cardiac Imaging and Diagnostics (4 papers)Pharmacological Effects of Natural Compounds (3 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Xu Li
53 papers receiving 577 citations
Peers
Comparison fields: 5 of 95
- Oncology 182
- Molecular Biology 177
- Surgery 110
- Epidemiology 103
- Cardiology and Cardiovascular Medicine 87
Countries citing papers authored by Xu Li
This map shows the geographic impact of Xu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Li more than expected).
Fields of papers citing papers by Xu Li
This network shows the impact of papers produced by Xu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Li. The network helps show where Xu Li may publish in the future.
Co-authorship network of co-authors of Xu Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Li. A scholar is included among the top collaborators of Xu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Li. Xu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 30 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 5 | |
| 15 | 5 | |
| 16 | 3 | |
| 17 | Lactic acid bacteria: mechanisms for cholesterol degradation in vitro and in vivo and its application. | 2 |
| 18 | Apoptosis of human gallbladder carcinoma GBC-SD cells induced by withaferin A and its possible mechanism | 1 |
| 19 | 3 | |
| 20 | 2 |
About Xu Li
Xu Li is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 64 papers that have together received 595 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (5 papers), Cardiac Imaging and Diagnostics (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Oncology (182 citations), Cancer Research (71 citations) and Rehabilitation (27 citations). Xu Li has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Wei Chen, Shuai Zhen, Chunrong Sun, Jiaojiao Lu, Quan Tang, Bing Xiao, Ping‐sheng Wu, Zhen‐shu Zhang, Qiang Ma and Ying Shen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.